生物
儿茶素
体外
代谢物
化学
生物化学
微生物代谢
新陈代谢
细菌
多酚
遗传学
抗氧化剂
作者
Qiqiong Li,Florence Van Herreweghen,Stanley Omondi Onyango,Marjan De Mey,Tom Van de Wiele
标识
DOI:10.1021/acs.jafc.2c00551
摘要
The bioavailability of catechin highly relies on gut microbiota which may determine its metabolic profile, resulting in different health outcomes. Here, we investigated in vitro (+)-catechin metabolism by human microbial communities. There were substantial interindividual differences in the metabolic profiles of (+)-catechin, with 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone being the major contributor. Furthermore, the microbial metabolic rate of catechin enabled stratification of 12 participants (fast, medium, and slow converters), despite the interference from the strong intrinsic interindividual variability in fecal microbiota. Correlations were established between this stratified population and microbiota features, such as ecosystem diversity. Additionally, fast converters had significantly higher prevalences of amplicon sequence variants (ASVs) with potential capacity of C-ring cleavage (ASV233_ Eggerthella and ASV402_ Eubacterium ), B-ring dihydroxylation (ASV402_ Eubacterium ), and short-chain fatty acid (SCFA)-producing ASVs. In conclusion, metabolic-capability-based stratification allows us to uncover differences in microbial composition between fast and slow converters, which could help to elucidate interindividual variabilities in the health benefits of catechins.
科研通智能强力驱动
Strongly Powered by AbleSci AI